| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.4 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.4 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |